Sensei Biotherapeutics, Inc. has filed an 8-K report to disclose a material event following its 2026 annual stockholder meeting. The filing pertains to significant capital and compensation decisions made at the meeting.
Sensei Biotherapeutics Files 8-K Reporting Material Event from Shareholder Meeting
8K_filingcorporate_eventbiotechnologyshareholder_meeting


